Skip to main content
C

CanBas Co.,Ltd. — Investor Relations & Filings

Ticker · 4575 ISIN · JP3244570002 T Professional, scientific and technical activities
Open in API
Filings indexed 65 across all filing types
Latest filing 2016-09-27 Annual Report
Country JP Japan
Listing T 4575

About CanBas Co.,Ltd.

https://www.canbas.co.jp/

CanBas is a clinical-stage biopharmaceutical company dedicated to the research and development of novel therapeutics for cancer patients. The company focuses on drug discovery in the field of oncology, including immuno-oncology and treatments targeting the cell cycle. Its pipeline includes CBP501, a calmodulin-modulating peptide that has undergone Phase II clinical trials. CanBas leverages proprietary screening systems and core technologies to develop innovative anti-cancer agents, with a focus on creating treatments with potentially fewer side effects.

Recent filings

Filing Released Lang Actions
有価証券報告書－第17期(2015/07/01－2016/06/30)
Annual Report Classification · 1% confidence The document is a Japanese '有価証券報告書' (Yuuka Shouken Houkokusho), which is the standard Japanese equivalent of a 10-K annual report. It contains detailed financial statements, business descriptions, and corporate information for the fiscal year ending June 30, 2016. It is a comprehensive report, not an announcement or a summary. FY 2016
2016-09-27 Japanese
四半期報告書－第17期第3四半期(2016/01/01－2016/03/31)
Interim / Quarterly Report Classification · 1% confidence The document is a 'Quarterly Report' (四半期報告書) for the third quarter of the 17th fiscal period of CanBas Co., Ltd. It contains detailed financial statements, including the balance sheet and income statement, as well as management analysis and auditor review information. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). 9M 2016
2016-05-13 Japanese
四半期報告書－第17期第2四半期(2015/10/01－2015/12/31)
Interim / Quarterly Report Classification · 1% confidence The document is a 'Quarterly Report' (四半期報告書) filed by CanBas Co., Ltd. in Japan. It contains detailed financial statements, including the balance sheet and income statement for the second quarter, as well as management's discussion and analysis (MD&A) of the financial results. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). Q2 2016
2016-02-12 Japanese
四半期報告書－第17期第1四半期(2015/07/01－2015/09/30)
Interim / Quarterly Report Classification · 1% confidence The document is a 'Quarterly Report' (四半期報告書) for the first quarter of the 17th fiscal period (July 1, 2015 to September 30, 2015) for CanBas Co., Ltd. It contains detailed financial statements, management analysis, and business status updates, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2016
2015-11-13 Japanese
有価証券報告書－第16期(2014/07/01－2015/06/30)
Annual Report Classification · 1% confidence The document is a 'Yuka Shoken Hokokusho' (Annual Securities Report) for the company 'CanBas Co., Ltd.' for the fiscal year ending June 30, 2015. This is the primary annual financial disclosure document required by the Financial Services Agency of Japan under the Financial Instruments and Exchange Act. It contains comprehensive financial statements, business descriptions, and management information. In the context of the provided filing categories, this corresponds to the '10-K' (Annual Report) equivalent for Japanese companies. FY 2015
2015-09-25 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.